journal article·2021-02-01Open access

Cocrystal Prediction Using Machine Learning Models and Descriptors

Medard Edmund Mswahili, Min-Jeong Lee, Gati Lother Martin, Junghyun Kim, Paul Kim, Guang J. Choi, Young-Seob Jeong

Applied Sciences· Volume 11· Issue 3

Abstract

Cocrystals are of much interest in industrial application as well as academic research, and screening of suitable coformers for active pharmaceutical ingredients is the most crucial and challenging step in cocrystal development. Recently, machine learning techniques are attracting researchers in many fields including pharmaceutical research such as quantitative structure-activity/property relationship. In this paper, we develop machine learning models to predict cocrystal formation. We extract descriptor values from simplified molecular-input line-entry system (SMILES) of compounds and compare the machine learning models by experiments with our collected data of 1476 instances. As a result, we found that artificial neural network shows great potential as it has the best accuracy, sensitivity, and F1 score. We also found that the model achieved comparable performance with about half of the descriptors chosen by feature selection algorithms. We believe that this will contribute to faster and more accurate cocrystal development.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · Computational Drug Discovery Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of ICT Convergence, Soonchunhyang University, Asan-si 31538, Korea

Department of Pharmaceutical Engineering, Soonchunhyang University, Asan-si 31538, Korea

Department of Future Convergence Technology, Soonchunhyang University, Asan-si 31538, Korea

Department of Medical Science, Soonchunhyang University, Asan-si 31538, Korea

References (67)

Show source-provided references
1. Pharmaceutical cocrystal drug products: An outlook on product development10.1016/j.tips.2018.10.006 ↗
2. Impact of solid state properties on developability assessment of drug candidates10.1016/j.addr.2003.10.007 ↗
3. Novel cocrystals of gliclazide: Characterization and evaluation10.1039/C5CE02402A ↗
4. Pharmaceutical cocrystals and their physicochemical properties10.1021/cg900129f ↗
5. The role of cocrystals in pharmaceutical science10.1016/j.drudis.2008.03.004 ↗
6. Pharmaceutical Cocrystals as an Opportunity to Modify Drug Properties: From the Idea to Application: A Review10.2174/1381612824666171226130828 ↗
7. Pharmaceutical cocrystals: The coming wave of new drug substances10.1002/jps.23402 ↗
8. Pharmaceutical cocrystals: Walking the talk10.1039/C6CC02943D ↗
9. Pharmaceutical cocrystals: Along the path to improved medicines10.1039/C5CC08216A ↗
10. Pharmaceutical cocrystals: From serendipity to design to application10.1016/j.drudis.2018.11.023 ↗
11. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design10.1016/j.addr.2017.03.003 ↗
12. Advanced methodologies for cocrystal synthesis10.1016/j.addr.2017.07.008 ↗
13. Center for Drug Evaluation and Research (2018). Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry, Guidance Document.
14. Polymorphs, salts, and cocrystals: What’s in a name?10.1021/cg3002948 ↗
15. Knowledge-based approaches to co-crystal design10.1039/c4ce00316k ↗
16. Will they co-crystallize?10.1039/C7CE00587C ↗
17. Supramolecular synthons in crystal engineering—A new organic synthesis10.1002/anie.199523111 ↗
18. Almarsson, Ö., and Zaworotko, M.J. (2004). Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?. Chem. Commun., 1889–1896.10.1039/b402150a ↗
19. Building co-crystals with molecular sense and supramolecular sensibility10.1039/b505883j ↗
20. A million crystal structures: The whole is greater than the sum of its parts10.1021/acs.chemrev.9b00155 ↗
21. Knowledge-based H-bond prediction to aid experimental polymorph screening10.1039/b910882c ↗
22. Cambridge structural database analysis of molecular complementarity in cocrystals10.1021/cg800861m ↗
23. Acid–base crystalline complexes and the p K a rule10.1039/c2ce26055g ↗
24. Co-crystals and molecular salts of carboxylic acid/pyridine complexes: Can calculated p K a’s predict proton transfer? A case study of nine complexes10.1039/C5CE00102A ↗
25. Evaluating the energetic driving force for cocrystal formation10.1021/acs.cgd.7b01375 ↗
26. Towards prediction of stoichiometry in crystalline multicomponent complexes10.1002/chem.200800668 ↗
27. Can the formation of pharmaceutical cocrystals be computationally predicted? I. Comparison of lattice energies10.1021/cg800685z ↗
28. Can the formation of pharmaceutical cocrystals be computationally predicted? 2. Crystal structure prediction10.1021/ct8004326 ↗
29. Quantifying intermolecular interactions: Guidelines for the molecular recognition toolbox10.1002/anie.200301739 ↗
30. H-bond competition experiments in solution and the solid state10.1039/C5CE02223A ↗
31. Virtual cocrystal screening10.1039/c0sc00555j ↗
32. Validation of a computational cocrystal prediction tool: Comparison of virtual and experimental cocrystal screening results10.1021/cg401339v ↗
33. Reliability of the Hansen solubility parameters as co-crystal formation prediction tool10.1016/j.ijpharm.2019.01.007 ↗
34. Hansen solubility parameter as a tool to predict cocrystal formation10.1016/j.ijpharm.2011.01.030 ↗
35. Solvent-screening and co-crystal screening for drug development with COSMO-RS10.1186/1758-2946-4-S1-O14 ↗
36. Cocrystal Ternary Phase Diagrams from Density Functional Theory and Solvation Thermodynamics10.1021/acs.cgd.8b00923 ↗
37. Selection of effective cocrystals former for dissolution rate improvement of active pharmaceutical ingredients based on lipoaffinity index10.1016/j.ejps.2017.07.004 ↗
38. Affinity prediction computations and mechanosynthesis of carbamazepine based cocrystals10.1039/C9CE01160A ↗
39. Concepts of artificial intelligence for computer-assisted drug discovery10.1021/acs.chemrev.8b00728 ↗
40. Prediction of solid state properties of cocrystals using artificial neural network modeling10.1021/acs.cgd.7b00966 ↗
41. Distinguishing cocrystals from simple eutectic mixtures: Phenolic acids as potential pharmaceutical coformers10.1021/acs.cgd.8b00335 ↗
42. Cocrystals in the Cambridge Structural Database: A network approach10.1107/S2052520619004694 ↗
43. Machine-Learning-Guided Cocrystal Prediction Based on Large Data Base10.1021/acs.cgd.0c00767 ↗
44. Mordred: A molecular descriptor calculator10.1186/s13321-018-0258-y ↗
45. PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints10.1002/jcc.21707 ↗
46. PyDPI: Freely Available Python Package for Chemoinformatics, Bioinformatics, and Chemogenomics Studies10.1021/ci400127q ↗
47. Rcpi: R/Bioconductor package to generate various descriptors of proteins, compounds and their interactions10.1093/bioinformatics/btu624 ↗
48. Dragon Software: An Easy Approach to molecular descriptor calculations
49. Cinfony—Combining Open Source cheminformatics toolkits behind a common interface
50. Open Babel: An open chemical toolbox
51. The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo- and Bioinformatics10.1021/ci025584y ↗
52. Application of Multivariate Adaptive Regression Splines (MARSplines) Methodology for Screening of Dicarboxylic Acid Cocrystal Using 1D and 2D Molecular Descriptors10.1021/acs.cgd.9b00318 ↗
53. Deep learning for in vitro prediction of pharmaceutical formulations10.1016/j.apsb.2018.09.010 ↗
54. A Tutorial on Support Vector Machines for Pattern Recognition10.1023/A:1009715923555 ↗
55. Random Forests10.1023/A:1010933404324 ↗
56. Chen, T., and Guestrin, C. (2016, January 13–17). XGBoost: A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, San Francisco, CA, USA.10.1145/2939672.2939785 ↗
57. Nair, V., and Hinton, G.E. (2010, January 21–24). Rectified linear units improve restricted boltzmann machines. Proceedings of the 27th International Conference on International Conference on Machine Learning, Haifa, Israel.
58. Kingma, D.P., and Ba, J. (2015, January 7–9). Adam: A Method for Stochastic Optimization. Proceedings of the 3rd International Conference on Learning Representations, San Diego, CA, USA.
59. Jeong, Y.S., Woo, J., Lee, S., and Kang, A.R. (2020). Malware Detection of Hangul Word Processor Files Using Spatial Pyramid Average Pooling. Sensors, 20.10.3390/s20185265 ↗
60. Goo, C.W., Gao, G., Hsu, Y.K., Huo, C.L., Chen, T.C., Hsu, K.W., and Chen, Y.N. (2018, January 1–6). Slot-Gated Modeling for Joint Slot Filling and Intent Prediction. Proceedings of the 2018 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, New Orleans, LA, USA.10.18653/v1/N18-2118 ↗
61. Quantifying Urban Form: Compactness versus ‘Sprawl’10.1080/0042098042000309748 ↗
62. Statistical Analysis of Spatial Expression Pattern for Spatially Resolved Transcriptomic Studies10.1038/s41592-019-0701-7 ↗
63. Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information10.1021/ci00028a014 ↗
64. New Insights in Atom-Atom Interactions for Future Drug Design10.2174/156802612804547416 ↗
65. Convergence of the Electrostatic Interaction Based on Topological Atoms10.1021/jp011511q ↗
66. Co-crystal Prediction by Artificial Neural Networks10.1002/anie.202009467 ↗
67. Ramsundar, B. (2021, February 01). DeepChem. Available online: https://deepchem.io/.